The objective of this activity is to provide evidence-based information on the latest developments for the use of Bruton’s tyrosine kinase (BTK) inhibitors in patients with chronic lymphocytic leukemia (CLL). Given the demonstrated clinical benefit of BTKi therapy and its advantages over chemotherapy, it is essential for patients that the adoption of BTKi therapy continues to accelerate. Optimizing patient adherence to oral BTKis is vital to achieving efficacy and improving clinical outcomes. Hematology/oncology nurses must develop best practices for educating patients and monitoring adherence for those receiving oral BTKi therapy. Complicating the adherence landscape is the predominance of older patients with CLL, who are often on multiple medications and more complex regimens. As front-line caregivers, oncology nurses are optimally positioned to guide patients through therapy and properly manage adverse events that may arise with this therapy.

View All Speakers


Katherine Byar, MSN, ANP-BC, BMTCN

Gynecologic Oncology Nurse Practitioner University of Nebraska Medical Center Omaha, Nebraska
View Full Bio

Barbara Rogers, CRNP, MN, AOCN, ANP-BC

Adult Hematology-Oncology Nurse Practitioner Fox Chase Cancer Center Philadelphia, Pennsylvania
View Full Bio

Amy Goodrich, RN, MSN, CRNP-AC

Research Associate The Johns Hopkins School of Medicine Nurse Practitioner The Sidney Kimmel Cancer Center at Johns Hopkins Baltimore, Maryland
View Full Bio



In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is designated for 1.00 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.


Creative Educational Concepts, Inc. certifies this activity for 1.00 hour of participation.


Supported by an independent educational grant from AstraZeneca.

Virtual Meeting Information

CEC Oncology staff will provide secure login instructions upon scheduling your virtual chapter meeting.